CannTrust (CNTTQ)

Overall impact
B (68)

Commentary

CannTrust is a strong overall performer. With a 'B' rating of 67.8 for overall impact (78th percentile compared to all companies), CannTrust ranks 77th out of 154 industry peers, behind Adamis Pharmaceuticals, Benitec Biopharma, Aquinox Pharmaceuticals and 73 others, and ahead of Evolus, GenSight Biologics, Oyster Point Pharma and 74 others. On top material causes for CannTrust's industry (Pharmaceuticals & Biotech), CannTrust performs well in Reduced Use of tobacco (83.8 score), Accountable Institutions (88.6), Disease Eradication (96.4) and 3 other causes where it received an 'A' score and performs poorly in Decent, Safe Work Opportunities (35.9 score), Improved Mental Health (36.1) and Reduced Green House Gas Emissions (24.1).
Impact
Cause CNTTQ
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
576
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
On, Canada
Share classes
CNTTQ
Description
CannTrust Holdings Inc. produces and distributes medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is based in Vaughan, Canada.
Material causes
Ethos considers the following causes material for CannTrust, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.